Mepolizumab improves small airway function in severe eosinophilic asthma

L. Seccombe (Sydney, Australia), P. Rogers (Sydney, Australia), N. Reed (Sydney, Australia), T. Badal (Sydney, Australia), C. Thamrin (Sydney, Australia), G. King (Sydney, Australia), M. Peters (Sydney, Australia), C. Farah (Sydney, Australia)

Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Session: The value of lung function testing in various pathophysiological conditions
Session type: Thematic Poster
Number: 2434
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Seccombe (Sydney, Australia), P. Rogers (Sydney, Australia), N. Reed (Sydney, Australia), T. Badal (Sydney, Australia), C. Thamrin (Sydney, Australia), G. King (Sydney, Australia), M. Peters (Sydney, Australia), C. Farah (Sydney, Australia). Mepolizumab improves small airway function in severe eosinophilic asthma. 2434

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: